Cargando…
A Rare Case of Delayed Hypersensitivity Following COVID-19 Booster Necessitating Treatment With Dupilumab
Following vaccination, patients can develop symptoms of eczema flare, which could range from mild skin irritation and urticaria to diffuse skin involvement. Delayed immunologic reactions have been described in association with the novel mRNA COVID‐19 vaccines and boosters. We report the case of an 8...
Autores principales: | Hanoodi, Maryam, Logee DO, Kristin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182882/ https://www.ncbi.nlm.nih.gov/pubmed/37193457 http://dx.doi.org/10.7759/cureus.37544 |
Ejemplares similares
-
The Successful Treatment of COVID-19-Induced Bullous Pemphigoid With Dupilumab
por: Savoldy, Michelle A, et al.
Publicado: (2022) -
Delayed Hyperpigmented Injection Site Reactions Due to Chronic Dupilumab Use
por: Pacheco, Curtis S, et al.
Publicado: (2023) -
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020) -
Clinical Psoriasiform Dermatitis Following Dupilumab Use for Autoeczematization Secondary to Chronic Stasis Dermatitis
por: Schrom, Kory P, et al.
Publicado: (2020) -
Rise in the Number of Complex Skin Cancers Necessitates Establishing Mohs Micrographic Surgery Fellowships in Pakistan
por: Tariq, Shahan, et al.
Publicado: (2023)